Your session is about to expire
← Back to Search
Behavioral Therapy for Irritability in Autism(BTIA Trial)
BTIA Trial Summary
This trial is testing a new behavioral therapy to help adolescents on the autism spectrum with irritability and aggression. The goal is to see if it can help them develop skills to cope with frustration and the challenges of transitioning to adulthood.
- Autism Spectrum Disorder
- Disruptive Behavior
- Asperger Syndrome
- Pervasive Developmental Disorder
BTIA Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
BTIA Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
BTIA Trial Design
Find a Location
Who is running the clinical trial?
- This text is about people who are either free of medication or on stable medication.You must be able to speak and understand the language used in the therapy sessions.You currently have a mental health disorder that needs urgent treatment.You have a tendency to act out in angry or disruptive ways, such as getting easily irritated or having outbursts.You are able to speak and understand the language used in the therapy sessions.You have been diagnosed with autism spectrum disorder.You have frequent angry outbursts or get extremely irritable.You cannot change the intensity of your current treatment during the study., who reside in the city of
The city of __________ is looking for boys and girls, ages 12 to 18 years inclusive, who are interested in participating in the Youth Academy.You cannot make any changes to your current treatment plan during the trial.
- Group 1: Behavioral Therapy for Irritability in Autism (BTIA)
- Group 2: Psychoeducation and Supportive Therapy (PST)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment available for this clinical research endeavor?
"According to clinicaltrials.gov, this medical trial is currently in progress and actively recruiting patients for the study which began on December 10th 2020 with an update posted on May 18th 2022."
How many individuals are committing to participating in this clinical trial?
"Affirmative. Data on clinicaltrials.gov indicate that the medical trial, which was initially advertised on December 10th 2020, is currently enrolling participants. 126 individuals across 1 facility are sought out for this research endeavour."
Who is eligible to participate in this medical experiment?
"To be eligible for the trial, adolescents aged 12 to 18 with aggression must apply. A total of 126 participants will be accepted into this clinical study."
Does the participant criteria for this trial encompass those above 80 years of age?
"This clinical trial welcomes patients in the 12-18 year old age bracket."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends